Achillion Pharmaceuticals, Inc.

Q2 2015 13F Holders

Symbol
ACHN
CUSIP
00448Q201
Type
Equity
Class
COM
Num filings
186
Total reported value, excl. options
$955 M
Manager Report Date Value ($000) Shares Option Type